• Contents
  • Key Takeaways
  • Source
  • Full Notes
  • Support the Podcast
Longevity
4 Min Read
Last Updated: 28.06.23

Richard Miller, M.D., Ph.D.: The Gold Standard for Testing Longevity Drugs, the ITP

Richard Miller, a professor and Director of the Center for Aging Research, discusses the results of the Interventions Testing Programs (ITPs) animal study. The study evaluates the impact of molecules like rapamycin, metformin, and canagliflozin on aging, revealing both unexpected positive and negative findings. Attia provides insights into the outcomes and implications of these experiments.

Key Takeaways

High level takeaways from the episode.

This episode is in queue to be distilled. Check back soon for key takeaways + protocols.

Source

We recommend using this distillation as a supplemental resource to the source material.

  • Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP

    Attia The Drive #148

    Richard Miller, a professor and Director of the Center for Aging Research, explores the outcomes of the Interventions Testing Programs (ITPs) animal study. Attia provides insights into the surprising findings of molecules like rapamycin and metformin.

    Sourced from
    Youtube↗
    View Podcast

Full Notes

Support the Podcast